Drawing for O4CP

USPTO serial 79142146

O4CP

Reviewed by CopyMark Law Group

Reg. 4683186Status 404
Filing date
Status date
Registration date
Feb 10, 2015
Examiner
EULIN, INGRID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with O4CP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amy Wright

Amy Wright Taft Stettinius & Hollister LLPOne Indiana Square, Suite 3500Indianapolis, IN 46204UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, diseases of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; Pharmaceutical preparations for the treatment of cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, diseases of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; medicines for the treatment of cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, diseases of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; sanitary products for medicine, namely, sanitary towels and disinfectants for sanitary purposes; dietetic substances for medical use, namely, crackers adapted for medical use; food for babies; disinfectants, namely, all purpose disinfectants; fungicides, herbicides for agriculture and domestic use; medicated baths, namely, therapeutic medicated bath preparations; chemical preparations for medical or pharmaceutical use, namely, for treating cancer and infectious diseases, namely, respiratory infections, eye infections, topical infections, illnesses of the immune system, namely, autoimmune diseases, immunodeficiency syndromes, diseases of the cardiovascular system, diseases of the respiratory system, illnesses of the digestive system, diseases of the nervous system, psychiatric disorders, skin disorders and subcutaneous tissue disorders, renal and urinary disorders; medicinal herbs; herbal teas for medicinal purposes; parasiticides; sugar for medical placebo use and dietetic sugar for medical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 16, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 28, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 29, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 29, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 27, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 27, 2021C71TCANCELLED SECTION 71—
Feb 10, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 11, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 11, 2015FIMPFINAL DISPOSITION PROCESSED—
May 10, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 10, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 5, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 10, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 19, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2014ALIEASSIGNED TO LIE—
Sep 12, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2014RFNTREFUSAL PROCESSED BY IB—
Mar 12, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 12, 2014RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 11, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2014DOCKASSIGNED TO EXAMINER—
Feb 18, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 12, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 6, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance